Protagonist Therapeutics: Q2 Earnings Snapshot

Barchart · 1d ago

NEWARK, Calif. (AP) — NEWARK, Calif. (AP) — Protagonist Therapeutics Inc. (PTGX) on Wednesday reported second-quarter net income of $162.8 million.

The Newark, California-based company said it had profit of $2.29 per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $2.11 per share.

The biopharmaceutical company posted revenue of $213.5 million in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $220.3 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX